Hologic, Inc. (HOLX) Stock Analysis

66.04

0.54%Today

Market Cap

14.72B

Volume

1.65M

52W High

84.67

52W Low

51.90

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Contact Information

Website: https://www.hologic.com
Address: 250 Campus Drive
Country: US

Investment Analysis & Insights

Key Investment Highlights

Market Position: Healthcare leader with 14.72B market capitalization
Trading Volume: 1.65M shares traded today
Price Range: 52-week range of $51.90 - $84.67
Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:27.75

EPS:$2.38

Beta:0.56

Avg Volume:3.13M

Market Analysis for Hologic, Inc.

Hologic, Inc. (HOLX) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 14.72B, the company represents a significant player in its market. The stock is currently trading at $66.04 with a positivedaily change of 0.54%.

The company's 7063 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 27.75, beta of 0.56, and 52-week price range from $51.90 to $84.67when evaluating investment opportunities.